Health ❯ Public Health ❯ HIV/AIDS

Prevention

Lenacapavir PrEP Funding Funding Cuts Testing Vaccination Awareness Campaigns Treatment Policy PrEP (Pre-exposure Prophylaxis) Campaigns Pre-exposure Prophylaxis (PrEP) Long-acting Drugs Pre-exposure Prophylaxis Injectable Medications Testing and Treatment Medications PrEP Medication Awareness Education Drug Distribution Empowerment Activism International Aid Pre-Exposure Prophylaxis Innovative Tools Diversity and Inclusion Policy Changes Testing Programs Budget Cuts Domestic Programs

Canada Updates HIV Prevention Guidance, Endorses PrEP on Request

Authors frame the CMAJ update as a tool to expand equitable access after recent increases in HIV diagnoses.

UNAIDS Warns Global HIV Response Is in Crisis as Funding Cuts Gut Prevention

T-Boz Reimagines TLC’s ‘Creep’ as ‘So We PrEP’ for HIV Prevention Campaign

First Lenacapavir Shipments Reach Zambia and Eswatini as U.S. Excludes South Africa From Donated Doses

GLAAD Launches HBCU HIV Education Tour at Jackson State as Snoop Dogg Makes Surprise Appearance

South Africa Approves Twice-Yearly HIV Prevention Shot, Clearing Path to 2026 Rollout

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

Dua Lipa’s Surprise West Hollywood Set Caps National PrEP Day Drive

Deals Set $40 Generics of Twice-Yearly HIV Prevention Shot for 120 Countries by 2027

U.S. to Buy Lenacapavir PrEP Doses to Reach Up to 2 Million People by 2028

State Department Proposes Major Cut to PEPFAR Despite Congressional Reprieve

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

UN Warns US Aid Suspension Risks Reversing Global HIV Progress

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention